Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in J Invest Dermatol Retrieve available abstracts of 99 articles: HTML format Text format

Single Articles

February 2012
1. LADSTEIN RG , Bachmann IM, Straume O, Akslen LA, et al
   Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma.
   J Invest Dermatol. 2012 Feb 2. doi: 10.1038/jid.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. LEE JT , Herlyn M
   MEK'ing the Most of p53 Reactivation Therapy in Melanoma.
   J Invest Dermatol. 2012;132:263-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
3. TEJERA-VAQUERIZO A , Nagore E, Melendez JJ, Lopez-Navarro N, et al
   Chronology of Metastasis in Cutaneous Melanoma: Growth Rate Model.
   J Invest Dermatol. 2012 Jan 5. doi: 10.1038/jid.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. NIKOLAOU VA , Stratigos AJ, Flaherty KT, Tsao H, et al
   Melanoma: New Insights and New Therapies.
   J Invest Dermatol. 2012 Jan 5. doi: 10.1038/jid.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. FUJIMURA T , Ring S, Umansky V, Mahnke K, et al
   Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas.
   J Invest Dermatol. 2011 Dec 22. doi: 10.1038/jid.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. APLIN AE
   Axl of evil?
   J Invest Dermatol. 2011;131:2343-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
7. HELMBOLD P , Richter AM, Walesch S, Skorokhod A, et al
   RASSF10 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin but Uncommon in Nevus Cell Nevi.
   J Invest Dermatol. 2011 Nov 24. doi: 10.1038/jid.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. RAE J , Viros A, Hayward R, Bennett DC, et al
   (V600E)Braf::Tyr-CreERT2::K14-Kitl Mice Do Not Develop Superficial Spreading-Like Melanoma: Keratinocyte Kit Ligand Is Insufficient to "Translocate" (V600E)Braf-Driven Melanoma to the Epidermis.
   J Invest Dermatol. 2011 Nov 24. doi: 10.1038/jid.2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. SCURR LL , McKenzie HA, Becker TM, Irvine M, et al
   Selective loss of wild-type p16(INK4a) expression in human nevi.
   J Invest Dermatol. 2011;131:2329-32.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
10. REUSCHENBACH M , Sommerer C, Hartschuh W, Zeier M, et al
    Absence of Mismatch Repair Deficiency-Related Microsatellite Instability in Non-Melanoma Skin Cancer.
    J Invest Dermatol. 2011 Oct 20. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. KEMPKES C , Rattenholl A, Buddenkotte J, Strozyk E, et al
    Proteinase-Activated Receptors 1 and 2 Regulate Invasive Behavior of Human Melanoma Cells via Activation of Protein Kinase D1.
    J Invest Dermatol. 2011 Oct 13. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. LAW MH , Montgomery GW, Brown KM, Martin NG, et al
    Meta-Analysis Combining New and Existing Data Sets Confirms that the TERT-CLPTM1L Locus Influences Melanoma Risk.
    J Invest Dermatol. 2011 Oct 13. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles   
    
    
    
    
13. ARIS M , Zubieta MR, Colombo M, Arriaga JM, et al
    MART-1- and gp100-Expressing and -Non-Expressing Melanoma Cells Are Equally Proliferative in Tumors and Clonogenic In Vitro.
    J Invest Dermatol. 2011 Oct 13. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. JI Z , Njauw CN, Taylor M, Neel V, et al
    p53 Rescue through HDM2 Antagonism Suppresses Melanoma Growth and Potentiates MEK Inhibition.
    J Invest Dermatol. 2011 Oct 13. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. WILLENBERG A , Saalbach A, Simon JC, Anderegg U, et al
    Melanoma Cells Control HA Synthesis in Peritumoral Fibroblasts via PDGF-AA and PDGF-CC: Impact on Melanoma Cell Proliferation.
    J Invest Dermatol. 2011 Oct 13. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
16. WEISCHER M , Heerfordt IM, Bojesen SE, Eigentler T, et al
    CHEK2*1100delC and Risk of Malignant Melanoma: Danish and German Studies and Meta-Analysis.
    J Invest Dermatol. 2011 Sep 29. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SCHRAMM SJ , Campain AE, Scolyer RA, Yang YH, et al
    Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis.
    J Invest Dermatol. 2011 Sep 29. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KIOWSKI G , Biedermann T, Widmer DS, Civenni G, et al
    Engineering Melanoma Progression in a Humanized Environment In Vivo.
    J Invest Dermatol. 2011 Sep 1. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
19. FRANCO R , Scognamiglio G, Salerno V, Sebastiani A, et al
    Expression of the Anti-Apoptotic Protein BAG3 in Human Melanomas.
    J Invest Dermatol. 2011 Aug 18. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles   
    
    
    
    
20. NARAYAN R , Nguyen H, Bentow JJ, Moy L, et al
    Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma.
    J Invest Dermatol. 2011 Aug 18. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. GIROTTI MR , Fernandez M, Lopez JA, Camafeita E, et al
    SPARC Promotes Cathepsin B-Mediated Melanoma Invasiveness through a Collagen I/alpha2beta1 Integrin Axis.
    J Invest Dermatol. 2011 Aug 18. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. POLISENO L , Haimovic A, Christos PJ, Vega Y Saenz de Miera EC, et al
    Deletion of PTENP1 Pseudogene in Human Melanoma.
    J Invest Dermatol. 2011 Aug 11. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. BERWICK M , Begg CB, Armstrong BK, Reiner AS, et al
    Interaction of CDKN2A and Sun Exposure in the Etiology of Melanoma in the General Population.
    J Invest Dermatol. 2011 Aug 11. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
24. SENSI M , Catani M, Castellano G, Nicolini G, et al
    Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase.
    J Invest Dermatol. 2011 Jul 28. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. METZNER T , Bedeir A, Held G, Peter-Vorosmarty B, et al
    Fibroblast Growth Factor Receptors as Therapeutic Targets in Human Melanoma: Synergism with BRAF Inhibition.
    J Invest Dermatol. 2011 Jul 14. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KRENZER S , Peterziel H, Mauch C, Blaber SI, et al
    Expression and Function of the Kallikrein-Related Peptidase 6 in the Human Melanoma Microenvironment.
    J Invest Dermatol. 2011 Jul 14. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. MING ME
    The Search for a Chemoprevention Agent Effective against Melanoma: Considerations and Challenges.
    J Invest Dermatol. 2011;131:1401-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. BARD S , Kirsner RS
    Do nonsteroidal anti-inflammatory drugs prevent melanoma?
    J Invest Dermatol. 2011;131:1394.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
29. KAO WH , Riker AI, Kushwaha DS, Ng K, et al
    Upregulation of Fanconi Anemia DNA Repair Genes in Melanoma Compared with Non-Melanoma Skin Cancer.
    J Invest Dermatol. 2011 Jun 23. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles   
    
    
    
    
30. JUNG MK , Park Y, Song SB, Cheon SY, et al
    Erythroid Differentiation Regulator 1, an Interleukin 18-Regulated Gene, Acts as a Metastasis Suppressor in Melanoma.
    J Invest Dermatol. 2011 Jun 23. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. FUKUNAGA-KALABIS M , Roesch A, Herlyn M
    From Cancer Stem Cells to Tumor Maintenance in Melanoma.
    J Invest Dermatol. 2011 Jun 9. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. NARDIN A , Wong WC, Tow C, Molina TJ, et al
    Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma Lesions.
    J Invest Dermatol. 2011 Jun 9. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. JALILI A , Moser A, Pashenkov M, Wagner C, et al
    Polo-Like Kinase 1 Is a Potential Therapeutic Target in Human Melanoma.
    J Invest Dermatol. 2011 Jun 9. doi: 10.1038/jid.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ARBISER JL , Fisher DE
    Fisetin: A Natural Fist against Melanoma?
    J Invest Dermatol. 2011;131:1187-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. BECKER JC , Schrama D
    Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
    J Invest Dermatol. 2011;131:1185-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
36. APLIN AE , Kaplan FM, Shao Y
    Mechanisms of Resistance to RAF Inhibitors in Melanoma.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. DE GIORGI V , Pinzani P, Salvianti F, Grazzini M, et al
    Circulating Tumor Cells in Cutaneous Melanoma.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
38. WELS C , Joshi S, Koefinger P, Bergler H, et al
    Transcriptional Activation of ZEB1 by Slug Leads to Cooperative Regulation of the Epithelial-Mesenchymal Transition-Like Phenotype in Melanoma.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. ULMER A , Fierlbeck G
    Detecting Circulating Melanoma Cells.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
40. TSUNODA K , Oikawa H, Tada H, Tatemichi Y, et al
    Nucleus Accumbens-Associated 1 Contributes to Cortactin Deacetylation and Augments the Migration of Melanoma Cells.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. CHIMENTO SM , Kirsner RS
    Understanding the Role of c-Jun and Jun B Transcription Factors in Skin Cancer Developments.
    J Invest Dermatol. 2011;131:1002.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
42. LEE EJ , Lee YS, Hwang S, Kim S, et al
    N-(3,5-Dimethylphenyl)-3-Methoxybenzamide (A(3)B(5)) Targets TRP-2 and Inhibits Melanogenesis and Melanoma Growth.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
43. SHACKLETON M
    Pulling RANK: Are Some Melanoma Cells More Malignant than Others?
    J Invest Dermatol. 2011;131:814-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
44. RYU B , Moriarty WF, Stine MJ, Deluca A, et al
    Global Analysis of BRAF(V600E) Target Genes in Human Melanocytes Identifies Matrix Metalloproteinase-1 as a Critical Mediator of Melanoma Growth.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
45. CURIEL-LEWANDROWSKI C , Nijsten T, Gomez ML, Hollestein LM, et al
    Long-Term Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Cutaneous Melanoma: Results of a United States Case-Control Study.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. SCHRAMA D , Scherer D, Schneider M, Zapatka M, et al
    ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
47. SYED DN , Afaq F, Maddodi N, Johnson JJ, et al
    Inhibition of Human Melanoma Cell Growth by the Dietary Flavonoid Fisetin Is Associated with Disruption of Wnt/beta-Catenin Signaling and Decreased Mitf Levels.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. CHAPON M , Randriamampita C, Maubec E, Badoual C, et al
    Progressive Upregulation of PD-1 in Primary and Metastatic Melanomas Associated with Blunted TCR Signaling in Infiltrating T Lymphocytes.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. QI RQ , He L, Zheng S, Hong Y, et al
    BRAF Exon 15 T1799A Mutation Is Common in Melanocytic Nevi, but Less Prevalent in Cutaneous Malignant Melanoma, in Chinese Han.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. VAN DEN BOORN JG , Picavet DI, van Swieten PF, van Veen HA, et al
    Skin-Depigmenting Agent Monobenzone Induces Potent T-Cell Autoimmunity toward Pigmented Cells by Tyrosinase Haptenation and Melanosome Autophagy.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. WALKER GJ , Soyer HP, Handoko HY, Ferguson B, et al
    Superficial Spreading-Like Melanoma in Arf(-/-)::Tyr-Nras(Q61K)::K14-Kitl Mice: Keratinocyte Kit Ligand Expression Sufficient to "Translocate" Melanomas from Dermis to Epidermis.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
52. KUPAS V , Weishaupt C, Siepmann D, Kaserer ML, et al
    RANK Is Expressed in Metastatic Melanoma and Highly Upregulated on Melanoma-Initiating Cells.
    J Invest Dermatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
53. ZOU YF , Wang F, Feng XL
    TP53 Arg72Pro Polymorphism May Have Little Involvement in the Pathogenesis of Skin Cancer in Caucasians.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
54. SLOMINSKI AT , Zmijewski MA, Zbytek B, Brozyna AA, et al
    Regulated Proenkephalin Expression in Human Skin and Cultured Skin Cells.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. JOOSSE A , de Vries E, Eckel R, Nijsten T, et al
    Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. WEISS MB , Aplin AE
    Paying "particle" attention to novel melanoma treatment strategies.
    J Invest Dermatol. 2010;130:2699-701.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
57. OH KS , Emmert S, Tamura D, Digiovanna JJ, et al
    Multiple Skin Cancers in Adults with Mutations in the XP-E (DDB2) DNA Repair Gene.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
58. LANG JM , Shennan M, Njauw JC, Luo S, et al
    A Flexible Multiplex Bead-Based Assay for Detecting Germline CDKN2A and CDK4 Variants in Melanoma-Prone Kindreds.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. KWATRA SG
    Targeting X-Linked Inhibitor of Apoptosis Protein for Melanoma Therapy: The Need for More Homogeneous Samples and the Importance of Cell Lines.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
60. WERZOWA J , Koehrer S, Strommer S, Cejka D, et al
    Vertical Inhibition of the mTORC1/mTORC2/PI3K Pathway Shows Synergistic Effects against Melanoma In Vitro and In Vivo.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. KAPLAN FM , Mastrangelo MJ, Aplin AE
    The wrath of RAFs: rogue behavior of B-RAF kinase inhibitors.
    J Invest Dermatol. 2010;130:2669-71.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
62. PEREGO M , Alison MR, Mariani L, Rivoltini L, et al
    Spheres of Influence in Cancer Stem Cell Biology.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
63. NIESSNER H , Beck D, Sinnberg T, Lasithiotakis K, et al
    The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. SISKIND V , Hughes MC, Palmer JM, Symmons JM, et al
    Nevi, Family History, and Fair Skin Increase the Risk of Second Primary Melanoma.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. ZUCKERMAN JE , Hsueh T, Koya RC, Davis ME, et al
    siRNA Knockdown of Ribonucleotide Reductase Inhibits Melanoma Cell Line Proliferation Alone or Synergistically with Temozolomide.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. XU X , Zhong JF
    Circulating tumor cells and melanoma progression.
    J Invest Dermatol. 2010;130:2349-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
67. FUSI A , Reichelt U, Busse A, Ochsenreither S, et al
    Expression of the Stem Cell Markers Nestin and CD133 on Circulating Melanoma Cells.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. GRIEWANK KG , Bastian BC
    Comment on "Cutaneous Melanoma in Childhood and Adolescence Shows Frequent Loss of INK4A and Gain of KIT".
    J Invest Dermatol. 2010;130:2330-1.
    PubMed     Text format     Related articles   
    
    
    
    
69. TIAN F , Lee SW
    X-linked inhibitor of apoptosis protein as a therapeutic target in metastatic melanoma.
    J Invest Dermatol. 2010;130:2169-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
70. BOONYARATANAKORNKIT JB , Yue L, Strachan LR, Scalapino KJ, et al
    Selection of Tumorigenic Melanoma Cells Using ALDH.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. SCHERER D , Rachakonda PS, Angelini S, Mehnert F, et al
    Association Between the Germline MC1R Variants and Somatic BRAF/NRAS Mutations in Melanoma Tumors.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
72. JONSSON A , Tuominen R, Grafstrom E, Hansson J, et al
    High Frequency of p16(INK4A) Promoter Methylation in NRAS-Mutated Cutaneous Melanoma.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. CHEN Y , Bathula SR, Yang Q, Huang L, et al
    Targeted Nanoparticles Deliver siRNA to Melanoma.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. GUITERA P , Pellacani G, Crotty KA, Scolyer RA, et al
    The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face.
    J Invest Dermatol. 2010;130:2080-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
75. SCHATTON T , Frank MH
    The in vitro spheroid melanoma cell culture assay: cues on tumor initiation?
    J Invest Dermatol. 2010;130:1769-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. BALLARD CJ , Elgart GW, Kirsner RS
    Help in the diagnosis of melanoma?
    J Invest Dermatol. 2010;130:1763.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
77. GOULD ROTHBERG BE , Rimm DL
    Biomarkers: The Useful and the Not So Useful- An Assessment of Molecular Prognostic Markers for Cutaneous Melanoma.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. DE GIORGI V , Pinzani P, Salvianti F, Panelos J, et al
    Application of a Filtration- and Isolation-by-Size Technique for the Detection of Circulating Tumor Cells in Cutaneous Melanoma.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. HISCUTT EL , Hill DS, Martin S, Kerr R, et al
    Targeting X-Linked Inhibitor of Apoptosis Protein to Increase the Efficacy of Endoplasmic Reticulum Stress-Induced Apoptosis for Melanoma Therapy.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. LAIHIA JK , Kallio JP, Taimen P, Kujari H, et al
    Protodynamic Intracellular Acidification by cis-Urocanic Acid Promotes Apoptosis of Melanoma Cells In Vitro and In Vivo.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
81. KERK N , Strozyk EA, Poppelmann B, Schneider SW, et al
    The Mechanism of Melanoma-Associated Thrombin Activity and von Willebrand Factor Release from Endothelial Cells.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. BUSCH C , Geisler J, Knappskog S, Lillehaug JR, et al
    Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
83. LE MN , Chan JL, Rosenberg SA, Nabatian AS, et al
    The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. BECKER TM , Philipsz S, Scurr LL, Fung C, et al
    Oncogenic B-RAF(V600E) Promotes Anchorage-Independent Survival of Human Melanocytes.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
85. AUBIN F , Courivaud C, Bamoulid J, Loupy A, et al
    Influence of Cyclooxygenase-2 (COX-2) Gene Promoter Polymorphism at Position -765 on Skin Cancer after Renal Transplantation.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    April 2010
86. PEREGO M , Tortoreto M, Tragni G, Mariani L, et al
    Heterogeneous Phenotype of Human Melanoma Cells with In Vitro and In Vivo Features of Tumor-Initiating Cells.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. HERLYN M , Fukunaga-Kalabis M
    What is a good model for melanoma?
    J Invest Dermatol. 2010;130:911-2.
    PubMed     Text format     Related articles   
    
    
    
    
88. CARAMUTA S , Egyhazi S, Rodolfo M, Witten D, et al
    MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. ALEXANDRESCU DT , Kauffman CL, Jatkoe TA, Hartmann DP, et al
    Melanoma-Specific Marker Expression in Skin Biopsy Tissues as a Tool to Facilitate Melanoma Diagnosis.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. DAR AA , Majid S, Nosrati M, de Semir D, et al
    Functional Modulation of IGF-Binding Protein-3 Expression in Melanoma.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. DAMM S , Koefinger P, Stefan M, Wels C, et al
    HGF-Promoted Motility in Primary Human Melanocytes Depends on CD44v6 Regulated via NF-kappa B, Egr-1, and C/EBP-beta.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
92. HOLTERHUES C , Vries ED, Louwman MW, Koljenovic S, et al
    Incidence and Trends of Cutaneous Malignancies in the Netherlands, 1989-2005.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. CHARLES J , Di Domizio J, Salameire D, Bendriss-Vermare N, et al
    Characterization of Circulating Dendritic Cells in Melanoma: Role of CCR6 in Plasmacytoid Dendritic Cell Recruitment to the Tumor.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. YAMAGUCHI Y , Hearing VJ, Maeda A, Morita A, et al
    NADPH:quinone oxidoreductase-1 as a new regulatory enzyme that increases melanin synthesis.
    J Invest Dermatol. 2010;130:645-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. CHOI TY , Sohn KC, Kim JH, Kim SM, et al
    Impact of NAD(P)H:quinone oxidoreductase-1 on pigmentation.
    J Invest Dermatol. 2010;130:784-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
96. MADDODI N , Huang W, Havighurst T, Kim K, et al
    Induction of Autophagy and Inhibition of Melanoma Growth In Vitro and In Vivo by Hyperactivation of Oncogenic BRAF.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. STEVENS L , McClelland L, Fricke A, Williamson M, et al
    Plexin B1 Suppresses c-Met in Melanoma: A Role for Plexin B1 as a Tumor-Suppressor Protein through Regulation of c-Met.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
98. HE S , Yoon HS, Suh BJ, Eccles MR, et al
    PAX3 Is Extensively Expressed in Benign and Malignant Tissues of the Melanocytic Lineage in Humans.
    J Invest Dermatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. TERHEYDEN P , Houben R, Pajouh P, Thorns C, et al
    Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.
    J Invest Dermatol. 2010;130:314-6.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: